Publication | Open Access
The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations
19
Citations
14
References
2020
Year
Tolvaptan MR and tolvaptan IR demonstrated similar short-term efficacy, tolerability, and safety, with low impact on multiple measures of QOL. Conclusions regarding long-term efficacy are limited by the short duration of follow-up.
| Year | Citations | |
|---|---|---|
Page 1
Page 1